Literature DB >> 8769282

Gastric mucosal plasminogen activators in Helicobacter pylori infection.

J M Götz1, Y Vergouwe, H W Verspaget, I Biemond, C F Sier, C B Lamers, R A Veenendaal.   

Abstract

Long-term H. pylori associated gastritis is recognized as a pathogenic factor in gastric carcinogenesis. In gastric carcinomas the amount and activity of the tissue-type plasminogen activator (t-PA) have been reported to be decreased, whereas those of the urokinase-type plasminogen activator (u-PA) were increased, contributing to the neoplastic and invasive process. The present study was performed to determine t-PA and u-PA levels and activity in gastric mucosa from 102 patients and to investigate whether these levels are influenced by H. pylori infection. The antigen concentration and activity of t-PA and u-PA in corpus mucosa were low (P < 0.001) compared with those in antral mucosa, although for the u-PA activity this did not reach statistical significance. In H. pylori-associated antral gastritis the mucosal t-PA antigen concentration and activity were found to be decreased (P < 0.001) compared with normal mucosa, whereas in H. pylori-associated pangastritis the corpus t-PA levels were not affected. The antigen concentration and activity of u-PA were found to be significantly (P < 0.005) increased, both in H. pylori-associated gastritis of antrum and corpus mucosa. Levels of u-PA in histologically normal corpus mucosa of patients with an H. pylori-associated antral gastritis were also found to be increased (P < 0.05). In conclusion, the alterations in the plasminogen activator profile found in H. pylori-associated gastritis, ie, a decrease in t-PA and an increase in u-PA, show a similar tendency as the previously found alterations in gastric carcinomas, which provides additional support for the possible involvement of H. pylori-associated gastritis in the pathogenesis of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769282     DOI: 10.1007/bf02087903

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Quantitation of urokinase antigen in plasma and culture media by use of an ELISA.

Authors:  D J Binnema; J J van Iersel; G Dooijewaard
Journal:  Thromb Res       Date:  1986-09-01       Impact factor: 3.944

2.  Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.

Authors:  C F Sier; H W Verspaget; G Griffioen; J H Verheijen; P H Quax; G Dooijewaard; P A De Bruin; C B Lamers
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

3.  Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

Authors:  C F Sier; H W Verspaget; G Griffioen; S Ganesh; H J Vloedgraven; C B Lamers
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

4.  Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay.

Authors:  D C Rijken; V W van Hinsbergh; E H Sens
Journal:  Thromb Res       Date:  1984-01-15       Impact factor: 3.944

5.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

6.  Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.

Authors:  D A Waltz; L Z Sailor; H A Chapman
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 7.  Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  Plasminogen activators in the intestine of patients with inflammatory bowel disease.

Authors:  P A de Bruin; G Crama-Bohbouth; H W Verspaget; J H Verheijen; G Dooijewaard; I T Weterman; C B Lamers
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

9.  Prognostic value of the plasminogen activation system in patients with gastric carcinoma.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  3 in total

1.  Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.

Authors:  J M Götz; J L Thio; H W Verspaget; G J Offerhaus; I Biemond; C B Lamers; R A Veenendaal
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Plasminogen binding and activation at the surface of Helicobacter pylori CCUG 17874.

Authors:  M Pantzar; A Ljungh; T Wadström
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  Induction of brain microvascular endothelial cell urokinase expression by Cryptococcus neoformans facilitates blood-brain barrier invasion.

Authors:  Jamal Stie; Deborah Fox
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.